How COVID-19 Is Affecting Drug Supply Regulation
On April 30, the U.S. Food and Drug Administration issued new guidance regarding the exemption and exclusion from certain requirements of the Drug Supply Chain Security Act, or DSCSA, during the COVID-19...To view the full article, register now.
Already a subscriber? Click here to view full article